Novartis (RNAI Research and Development Portfolio) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Novartis (RNAI Research and Development Portfolio) General Information

Description

Provider of research and development services to the pharmaceutical industry. The company's services include computer modeling and simulation, clinical development, clinical trials and drug discovery for disorders ranging from cancer to degenerative diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Corporate Office
  • Lichtstrasse 35
  • 4056 Basel
  • Switzerland

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novartis (RNAI Research and Development Portfolio) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novartis (RNAI Research and Development Portfolio)‘s full profile, request access.

Request a free trial

Novartis (RNAI Research and Development Portfolio) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Novartis (RNAI Research and Development Portfolio)‘s full profile, request access.

Request a free trial

Novartis (RNAI Research and Development Portfolio) FAQs

  • Where is Novartis (RNAI Research and Development Portfolio) headquartered?

    Novartis (RNAI Research and Development Portfolio) is headquartered in Basel, Switzerland.

  • What industry is Novartis (RNAI Research and Development Portfolio) in?

    Novartis (RNAI Research and Development Portfolio)’s primary industry is Biotechnology.

  • Is Novartis (RNAI Research and Development Portfolio) a private or public company?

    Novartis (RNAI Research and Development Portfolio) is a Private company.

  • What is the current valuation of Novartis (RNAI Research and Development Portfolio)?

    The current valuation of Novartis (RNAI Research and Development Portfolio) is 0000.

  • What is Novartis (RNAI Research and Development Portfolio)’s current revenue?

    The current revenue for Novartis (RNAI Research and Development Portfolio) is 000000.

  • Who are Novartis (RNAI Research and Development Portfolio)’s investors?

    Novartis has invested in Novartis (RNAI Research and Development Portfolio).

  • When was Novartis (RNAI Research and Development Portfolio) acquired?

    Novartis (RNAI Research and Development Portfolio) was acquired on 05-Mar-2015.

  • Who acquired Novartis (RNAI Research and Development Portfolio)?

    Novartis (RNAI Research and Development Portfolio) was acquired by Arrowhead Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »